DRG uses cookies to improve your experience on this website. Some of the cookies we use are essential for parts of the website to operate. Please be aware that if you continue without changing your cookie settings, you consent to this. For more information on our use of cookies, please review our cookie policy.

Research & Reports

Searching in Biopharma (1958)

Dermatitis/Eczema | Epidemiology | Asia Pacific Data

Dermatitis/Eczema | Epidemiology | Asia Pacific Data

Thank you!

Your request has been received by DRG. A represantative will contact you shortly to provide more details on the research and data contained in this report and ensure that it will meet your current research needs.

DRG Epidemiology's coverage of dermatitis comprises epidemiological estimates of key patient populations across 45 countries worldwide. We report the prevalence of dermatitis for each country, as well as annualized case counts projected to the national population.

Most patient populations are forecast over a period of 20 years for the major mature pharmaceutical markets of the United States, Europe and Japan, and 10 years for the other countries covered in this report.

DRG Epidemiology's dermatitis forecast will answer the following questions:

  • How will demographic trends, such as population aging and improving life expectancy, affect the epidemiology of dermatitis over the forecast period?

All forecast data are available on the DRG Insights Platform in tabular format, with options to download to MS Excel. All populations are accompanied by a comprehensive description of the methods and data sources used, with hyperlinks to external sources. A summary evidence table generated as part of our systematic review of the epidemiological literature is also provided for full transparency into research and methods.

Note: coverage may vary by country.

Table of contents

  • Asia Pacific Data
    • Introduction
      • Key Findings
    • Epidemiology Data
    • Methods
      • 12-Month Total Prevalent Cases of Dermatitis
    • Reference Materials
      • Literature Review
      • Risk/Protective Factors
      • Bibliography

Already a Client? Log in to access this report.

  • Pub Date: November 2018
  • Author(s): Kurt White; Nicole Zhang, MPH
  • Kurt is an associate epidemiologist and joined Decision Resources Group in ; He has significant experience with statistical methods such as multivariate linear regression and logistic regression.  He completed his master’s and doctoral degree (MPH, PhD) in Epidemiology at Indiana University School of Public Health, where he worked on projects investigating the relationship between physical activity and infectious disease health ; He also completed his master’s (MA) in anthropology at Indiana University and his master’s (MS) in biology at Indiana University-Purdue University ;

  • Nicole Zhang is an Epidemiologist at Decision Resources Group. She focuses on the epidemiology of oncology and cardiovascular disorders. She holds an from Tufts Medical School where she specialized in epidemiology and biostatistics. She also holds a in Chemistry and Statistics from Mount Holyoke College. Prior to joining Decision Resources, she worked as a research analyst at Massachusetts General Hospital where she independently managed data from food information survey conducted in Chelsea, MA. She has also worked at Massachusetts Department of Public Health where she conducted secondary research in the fields of gestational diabetes.

Purchase Report

Recent reports:
You may also be interested in: